KF
NXTM

Kopp Funds’s NxStage Medical Inc. NXTM Stock Holding History

Kopp Funds’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$110K Buy
+11,020
New +$125K 0.05% 63

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

Kopp Funds's NXTM Position: Q4 2013 in Review

Kopp Funds opened a new position in NxStage Medical Inc. (NXTM) in Q4 2013: 11,020 shares worth $110K. The stake represents 0.05% of the portfolio and ranks #63 among its holdings.

114 funds tracked by Wall St. Rank hold NXTM as of Q4 2013.

  • Kopp Funds held 11,020 shares of NxStage Medical Inc. worth $110K as of Q4 2013.
  • NxStage Medical Inc. was a new Kopp Funds position in Q4 2013.
  • NxStage Medical Inc. made up 0.05% of Kopp Funds's portfolio in Q4 2013, its #63 holding.
  • 114 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2013.

Based on Kopp Funds's 13F filing for Q4 2013, filed 21 Jan 2014.